Trademark Overview
On Thursday, March 14, 2024, a trademark application was filed for ORZELIA with the United States Patent and Trademark Office. The USPTO has given the ORZELIA trademark a serial number of 98449739. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, September 24, 2024. This trademark is owned by GLAXO GROUP LIMITED. The ORZELIA trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, and psychiatric related diseases and disorders; all of the foregoing excluding pharmaceutical preparations for the treatment of auto-immune diseases or rheumatoid arthritis.